Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Re-evaluation of critical concentrations of antituberculosis fluoroquinolones in the Mycobacteria Growth Indicator Tube 960 system.

International journal of mycobacteriology - 1 Jan 2000

Rupasinghe Praharshinie, Driesen Michele, Vereecken Jens, de Jong Bouke C, Rigouts Leen

Abstract excerpt

Background: Fluoroquinolones (FQs) have substantial activity against the Mycobacterium tuberculosis complex (MTBc) by preventing bacterial DNA synthesis through DNA gyrase inhibition. The reference standard for FQ-resistance testing is phenotypic drug-susceptibility testing (pDST) based on growth inhibition of MTBc in drug-containing Mycobacteria Growth Indicator Tube system (MGIT) media at a critical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to DNA Gyrase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Fluoroquinolones

Share to Microbial Sensitivity Tests

Share to Mutation

Share to Mycobacterium tuberculosis

Source

Identifiers

PMID: 37721239
DOI: 10.4103/ijmy.ijmy_144_23

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Re-evaluation of critical concentrations of antituberculosis fluoroquinolones in the Mycobacteria Growth Indicator Tube 960 system.PMID 37721239Read ↗

Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration.Semantic proximity Read ↗

Diagnostics and new treatment regimens for TB: can the Xpert MTB/XDR assay fill the gap for fluoroquinolone testing?Semantic proximity Read ↗

Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed rpoB Mutations and Discordant Susceptibility Phenotypes.Semantic proximity Read ↗

Determination of Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Para-Aminosalicylic Acid with clinical isolates with thyA, folC and dfrA mutationsSemantic proximity Read ↗

Specific <i>gyrA</i> gene mutations correlate with high prevalence of discordant levofloxacin resistance in <i>Mycobacterium tuberculosis</i> isolates from Beijing, ChinaSemantic proximity Read ↗

Current drug susceptibility testing in the Löwenstein-Jensen medium leads to underestimating of prothionamide resistance in multi-drug resistant Mycobacterium tuberculosis.Semantic proximity Read ↗

Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.Semantic proximity Read ↗

Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones inMycobacterium tuberculosisSemantic proximity Read ↗

Discordance in genotypic and phenotypic drug susceptibility results: time to reconsider critical concentration of rifampicinSemantic proximity Read ↗

Discordance in Genotypic and Phenotypic anti-tuberculosis drug susceptibility results: time to reconsider critical concentrationSemantic proximity Read ↗

Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis.Semantic proximity Read ↗

Minimum inhibitory concentration of cycloserine against Mycobacterium tuberculosis using the MGIT 960 system and a proposed critical concentration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.